Literature DB >> 7770672

Malignant breast lesions that may mimic benign tumors.

N Weidner1.   

Abstract

It has been estimated that approximately 1 in 9 women (living to age 85 years) in the United States will develop breast cancer at some time in their lives; hence the interpretation of breast biopsies has become a large and important component of the surgical pathologist's practice. Indeed, there is great pressure on surgical pathologists to make accurate diagnoses of breast lesions because of their high incidence, the increased public awareness of breast disease, the greater use of screening mammography to detect early carcinomas, the development of multiple therapeutic options (which is often determined by tumor pathology), and the harsh medical-legal climate. The focus of this article will be to define the clinicopathologic features of two malignant breast lesions that are particularly prone to simulate benign lesions, and thus pose important diagnostic problems to surgical pathologists. The two lesions include spindle-cell carcinoma and low-grade duct carcinoma in situ.

Entities:  

Mesh:

Year:  1995        PMID: 7770672

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  3 in total

1.  [Flat epithelial atypia].

Authors:  W Böcker; D Hungermann; J Tio; S Weigel; T Decker
Journal:  Pathologe       Date:  2009-02       Impact factor: 1.011

2.  Epithelial atypia in biopsies performed for microcalcifications. practical considerations about 2,833 serially sectioned surgical biopsies with a long follow-up.

Authors:  Isabelle de Mascarel; Gaëtan MacGrogan; Simone Mathoulin-Pélissier; Anne Vincent-Salomon; Isabelle Soubeyran; Véronique Picot; Jean-Michel Coindre; Louis Mauriac
Journal:  Virchows Arch       Date:  2007-06-06       Impact factor: 4.064

Review 3.  The diagnosis and management of pre-invasive breast disease: flat epithelial atypia--classification, pathologic features and clinical significance.

Authors:  Stuart J Schnitt
Journal:  Breast Cancer Res       Date:  2003-07-29       Impact factor: 6.466

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.